< Back
EMWA Logo EMWA Logo
 

Thomas Schindler

Company:
Lay & Regulatory Writing
Qualification:
PhD
Leader background:
Thomas M Schindler studied biology and linguistics in Germany and the UK, obtained a PhD in molecular physiology, and did postdoctoral research in the UK. Thereafter, he became an editor of popular science books in biology, geography, and astronomy. He then turned to medical writing and has now gained some 25 years of experience in both medical affairs and regulatory medical writing including the preparation of all documents for marketing authorization applications around the globe. He founded and established the medical writing function at Boehringer Ingelheim and has recently headed the Innovation Medical Writing Group focussing on lay communication, good graphics development, video creation and AI-driven writing. He was a member of the TransCelerate Return of Results work stream, is contributing to the Good Lay Summary Practice initiative and the PFMD Plain Language Summary guidance.
Workshops:
Slippery Slopes: Survival Analysis
    Level: Advanced Area: Professional Techniques
    Code: PTA3c Duration: 03:30:00
Summarising Clinical Efficacy Data for a New Drug Application
    Level: Advanced Area: Drug Development
    Code: DDA23 Duration: 03:30:00
Slippery Slopes: Survival Analysis
    Level: Advanced Area: Professional Techniques
    Code: PTA3d Duration: 03:30:00
Writing Lay Language Summaries of Study Results according to EU Regulation
    Level: Advanced Area: Medical Communication
    Code: MCA7 Duration: 03:30:00
Disclosure of Clinical Regulatory Documentation - The Company Perspective (How do we disclose documentation?)
    Level: Area:
    Code: Sym5.7 Duration: 00:45:00
Clinical Study Reports in Oncology
    Level: Advanced Area: Drug Development
    Code: DDA24a Duration: 03:30:00
Predatory publishing - how to identify it, fight it, and how to develop predatory-safe practices
    Level: Not for credit Area: Short Seminar
    Code: SEMPR Duration: 00:50:00
Writing Lay Language Summaries of Study Results according to EU Regulation
    Level: Advanced Area: Medical Communication
    Code: MCA7a Duration: 03:30:00
Clinical Study Reports in Oncology
    Level: Advanced Area: Drug Development
    Code: DDA24b Duration: 03:30:00